Clinical Trials · NCT04060992
Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual Cycle
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- University of Southern California
- Enrollment
- 12
- Start date
- Oct 2019
- Locations
- See registry
- Primary endpoint
- Suppression of gonadotropin and pituitary hormones as measured by hormonal assay status post short-term administration of elagolix